logo
An exoplanet called K2-18b is highlighting the complexities of finding life beyond Earth

An exoplanet called K2-18b is highlighting the complexities of finding life beyond Earth

CNN06-06-2025

A tiny sign revealed in April seemed like it might change the universe as we know it.
Astronomers had detected just a hint, a glimmer of two molecules swirling in the atmosphere of a distant planet called K2-18b — molecules that on Earth are produced only by living things. It was a tantalizing prospect: the most promising evidence yet of an extraterrestrial biosignature, or traces of life linked to biological activity.
But only weeks later, new findings suggest the search must continue.
'It was exciting, but it immediately raised several red flags because that claim of a potential biosignature would be historic, but also the significance or the strength of the statistical evidence seemed to be too high for the data,' said Dr. Luis Welbanks, a postdoctoral research scholar at Arizona State University's School of Earth and Space Exploration.
While the molecules identified on K2-18b by the April study — dimethyl sulfide, or DMS, and dimethyl disulfide, or DMDS — are associated largely with microbial organisms on our planet, scientists point out that the compounds can also form without the presence of life. Now, three teams of astronomers not involved with the research, including Welbanks, have assessed the models and data used in the original biosignature discovery and got very different results, which they have submitted for peer review.
Meanwhile, the lead author of the April study, Nikku Madhusudhan, and his colleagues have conducted additional research that they say reinforces their previous finding about the planet. And it's likely that additional observations and research from multiple groups of scientists are on the horizon.
The succession of research papers revolving around K2-18b offers a glimpse of the scientific process unfolding in real time. It's a window into the complexities and nuances of how researchers search for evidence of life beyond Earth — and shows why the burden of proof is so high and difficult to reach.
Located 124 light-years from Earth, K2-18b is generally considered a worthy target to scour for signs of life. It is thought to be a Hycean world, a planet entirely covered in liquid water with a hydrogen-rich atmosphere, according to previous research led by Madhusudhan, a professor of astrophysics and exoplanetary science at the University of Cambridge's Institute of Astronomy. And as such, K2-18b has rapidly attracted attention as a potentially habitable place beyond our solar system.
Convinced of K2-18b's promise, Madhusudhan and his Cambridge colleagues used observations of the planet by the largest space telescope in operation, the James Webb Space Telescope, to study the planet further. But two scientists at the University of Chicago — Dr. Rafael Luque, a postdoctoral scholar in the university's department of astronomy and astrophysics, and Michael Zhang, a 51 Pegasi b / Burbidge postdoctoral fellow — spotted some problems with what they found.
After reviewing Madhusudhan and his team's April paper, which followed up on their 2023 research, Luque and Zhang noticed that the Webb data looked 'noisy,' Luque said.
Noise, caused by imperfections in the telescope and the rate at which different particles of light reach the telescope, is just one challenge astronomers face when they study distant exoplanets. Noise can distort observations and introduce uncertainties into the data, Zhang said.
Trying to detect specific gases in distant exoplanet atmospheres introduces even more uncertainty. The most noticeable features from a gas like dimethyl sulfide stem from a bond of hydrogen and carbon molecules — a connection that can stretch and bend and absorb light at different wavelengths, making it hard to definitively detect one kind of molecule, Zhang said.
'The problem is basically every organic molecule has a carbon-hydrogen bond,' Zhang said. 'There's hundreds of millions of those molecules, and so these features are not unique. If you have perfect data, you can probably distinguish between different molecules. But if you don't have perfect data, a lot of molecules, especially organic molecules, look very similar, especially in the near-infrared.'
Delving further into the paper, Luque and Zhang also noticed that the perceived temperature of the planet appeared to increase sharply from a range of about 250 Kelvin to 300 Kelvin (-9.67 F to 80.33 F or -23.15 C to 26.85 C) in research Madhusudhan published in 2023 to 422 Kelvin (299.93 F or 148.85 C) in the April study.
Such harsh temperatures could change the way astronomers think about the planet's potential habitability, Zhang said, especially because cooler temperatures persist in the top of the atmosphere — the area that Webb can detect — and the surface or ocean below would likely have even higher temperatures.
'This is just an inference only from the atmosphere, but it would certainly affect how we think about the planet in general,' Luque said.
Part of the issue, he said, is that the April analysis didn't include data collected from all three Webb instruments Madhusudhan's team used over the past few years. So Luque, Zhang and their colleagues conducted a study combining all the available data to see whether they could achieve the same results, or even find a higher amount of dimethyl sulfide. They found 'insufficient evidence' of both molecules in the planet's atmosphere.
Instead, Luque and Zhang's team spotted other molecules, like ethane, that could fit the same profile. But ethane does not signify life.
Arizona State's Welbanks and his colleagues, including Dr. Matt Nixon, a postdoctoral researcher in the department of astronomy at the University of Maryland College Park, also found what they consider a fundamental problem with the April paper on K2-18b.
The concern, Welbanks said, was with how Madhusudhan and his team created models to show which molecules might be in the planet's atmosphere.
'Each (molecule) is tested one at a time against the same minimal baseline, meaning every single model has an artificial advantage: It is the only explanation permitted,' Welbanks said.
When Welbanks and his team conducted their own analysis, they expanded the model from Madhusudhan's study.
'(Madhusudhan and his colleagues) didn't allow for any other chemical species that could potentially be producing these small signals or observations,' Nixon said. 'So the main thing we wanted to do was assess whether other chemical species could provide an adequate fit to the data.'
When the model was expanded, the evidence for dimethyl sulfide or dimethyl disulfide 'just disappears,' Welbanks said.
Madhusudhan believes the studies that have come out after his April paper are 'very encouraging' and 'enabling a healthy discussion on the interpretation of our data on K2-18b.'
He reviewed Luque and Zhang's work and agreed that their findings don't show a 'strong detection for DMS or DMDS.' When Madhusudhan's team published the paper in April, he said the observations reached the three-sigma level of significance, or a 0.3% probability that the detections occurred by chance.
For a scientific discovery that is highly unlikely to have occurred by chance, the observations must meet a five-sigma threshold, or below a 0.00006% probability that the observations occurred by chance. Meeting such a threshold will require many steps, Welbanks said, including repeated detections of the same molecule using multiple telescopes and ruling out potential nonbiological sources.
While such evidence could be found in our lifetime, it is less likely to be a eureka moment and more a slow build requiring a consensus among astronomers, physicists, biologists and chemists.
'We have never reached that level of evidence in any of our studies,' Madhusudhan wrote in an email. 'We have only found evidence at or below 3-sigma in our two previous studies (Madhusudhan et al. 2023 and 2025). We refer to this as moderate evidence or hints but not a strong detection. I agree with (Luque and Zhang's) claim which is consistent with our study and we have discussed the need for stronger evidence extensively in our study and communications.'
In response to the research conducted by Welbanks' team, Madhusudhan and his Cambridge colleagues have authored another manuscript expanding the search on K2-18b to include 650 types of molecules. They have submitted the new analysis for peer review.
'This is the largest search for chemical signatures in an exoplanet to date, using all the available data for K2-18b and searching through 650 molecules,' Madhusudhan said. 'We find that DMS continues to be a promising candidate molecule in this planet, though more observations are required for a firm detection as we have noted in our previous studies.'
Welbanks and Nixon were pleased that Madhusudhan and his colleagues addressed the concerns raised but feel that the new paper effectively walks back central claims made in the original April study, Welbanks said.
'The new paper tacitly concedes that the DMS/DMDS detection was not robust, yet still relies on the same flawed statistical framework and a selective reading of its own results,' Welbanks said in an email. 'While the tone is more cautious (sometimes), the methodology continues to obscure the true level of uncertainty. The statistical significance claimed in earlier work was the product of arbitrary modeling decisions that are not acknowledged.'
Luque said the Cambridge team's new paper is a step in the right direction because it explores other possible chemical biosignatures.
'But I think it fell short in the scope,' Luque said. 'I think it restricted itself too much into being a rebuttal to the (Welbanks) paper.'
Separately, however, the astronomers studying K2-18b agree that pushing forward on researching the exoplanet contributes to the scientific process.
'I think it's just a good, healthy scientific discourse to talk about what is going on with this planet,' Welbanks said. 'Regardless of what any single author group says right now, we don't have a silver bullet. But that is exactly why this is exciting, because we know that we're the closest we have ever been (to finding a biosignature), and I think we may get it within our lifetime, but right now, we're not there. That is not a failure. We're testing bold ideas.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

White House Aims To Halt Fantastical NASA Missions Across Solar System
White House Aims To Halt Fantastical NASA Missions Across Solar System

Forbes

time2 hours ago

  • Forbes

White House Aims To Halt Fantastical NASA Missions Across Solar System

The New Horizons spacecraft sends back its sensational snapshots of Jupiter, and its volcanic moon ... More Io, before the mission's close encounter with Pluto (Photo by: Photo12/Universal Images Group via Getty Images) Universal Images Group via Getty Images The White House bid to terminate NASA's leading-edge flights of exploration 'across the solar system' threatens to explode American leadership in discoveries that have reshaped civilization since the rise of the first Space Age, says one of the world's top planetary scientists. As space powers across the continents vie to map and image planets and moons, comets and ice-worlds circling the sun, slashes to NASA's funding would represent a great leap backward, crippling it even as rivals race ahead, says Alan Stern, a one-time leader at NASA and a globally acclaimed space scientist. The president's new proposed budget drastically cuts appropriations for NASA, with outlays for its planetary science missions—the exploration of Pluto and other celestial worlds by space-borne rockets and robots, cameras and telescopes—axed almost in half. Now facing the guillotine—inexplicably—are constellations of technologically advanced space probes developed by NASA and spearheading scientists across America, including the Juno imager now orbiting Jupiter, the Mars Odyssey and Maven spacecraft gliding above Mars and the asteroid hunter OSIRIS-Apophis. NASA's Mars Odyssey spacecraft, in orbit around Mars, is one of the leading-edge explorers slated to ... More be terminated by the White House. Shown here is an artist's impression of the orbiter. (Photo) Getty Images 'Incredibly, this budget proposes to turn off 55 perfectly working, productive spacecraft across the solar system,' Dr. Stern, who once headed NASA's Science Mission Directorate, tells me in an interview. Stern took up that post after conceiving and designing one of the American space agency's most sensational missions ever - the New Horizons spacecraft that aced a close approach with Pluto while sending back fantastical images of the otherworldly orb and its moons - a miniature planetary system that generated billions of hits when it began beaming down across NASA's website. While New Horizons continues its super-speed flight through the outer solar system, charting the mysterious frozen reaches of the Kuiper belt, the president's plan calls for the spacecraft to be cast away. Abandoning the $900-million mission in order to recoup the minimal costs of its ongoing operation makes no sense economically or scientifically, Stern says. The robotic photographer New Horizons images Pluto as it speeds through the outer solar system ... More (Photo by NASA/APL/SwRI via Getty Images) Getty Images 'With New Horizons,' he says, 'there are a lot of important scientific objectives still ahead, things no other spacecraft can do.' 'Terminating this mission would also represent a tragic loss of soft power projection for the U.S.' The Horizons craft, and its array of next-generation cameras and spectrometers, is exploring a region beyond Pluto that no other human-created probe has ever entered, with a treasure trove of potential discoveries waiting. 'This would be like sending a message to [Christopher] Columbus to sink his ships while they were in North America,' Stern tells me, upending a new age of discovery. 'With New Horizons, we have the power and the fuel to run this mission for another 20 years … and we have more Kuiper belt objects to explore.' The White House, in issuing its slashed budget plan for NASA, never provided a logical rationale for torpedoing some of the agency's world-leading missions to survey and image the solar system. Its inscrutable sinking of some of these vanguard voyages was unveiled with the terseness of a telegram: 'Operating missions that have completed their prime missions (New Horizons and Juno) and the follow-on mission to OSIRIX-REx, OSIRIS-Apophis Explorer, are eliminated.' The asteroid-hunter OSIRIS spacecraft, shown here at the Kennedy Space Center in Florida, is one of ... More the trailblazers set to be terminated by the White House. (Photo by Bruce Weaver / AFP) (Photo by BRUCE WEAVER/AFP via Getty Images) AFP via Getty Images The OSIRIS spacecraft, which had been slated to rendezvous with the closely approaching Apophis asteroid ahead, is a precursor mission to defending the Earth's eight billion citizens against doomsday cosmic strikes by colossal comets or asteroids of the future. The robotic photographer Juno has snapped an endless kaleidoscope of imagery as it floats around Jupiter. Scientists at NASA's Jet Propulsion Lab have posted raw impressions of the orb and its moons and invited 'citizen scientists' to Photoshop and launch them across the cybersphere. In the process, they are becoming part of the spacefaring civilization that is spreading out across the globe. Model of the $1-billion Juno spacecraft, which is now orbiting and photographing Jupiter (Photo by ... More) Getty Images During its own space odyssey, New Horizons has astounded stargazers, students and scholars worldwide with its technicolor panoramas of Pluto, covered in surreal ice-fields and cryo-volcanoes, and its age-old companion Charon. The twin netherworlds—named after the mythical Greek god of the underworld and the pilot who shuttled souls across the river Styx—circle more than five billion kilometers distant from the sun, along an orbit that Stern's Pluto expedition took nine years to reach. Now, even as it whizzes beyond all of the classical planets, New Horizons, and its future, has entered the purgatory of potential excommunication by mission controllers—and their masters—six worlds away. The New Horizons spacecraft, now speeding through the outer solar system, could be jettisoned under ... More a White House plan that would destroy American leadership in planetary science missions. (Photo by Heritage Art/Heritage Images via Getty Images) Heritage Images via Getty Images 'This is a vast and tragic mistake,' Stern says, 'because the issue is larger than just NASA, it also affects U.S. world leadership [and] responsible government that protects taxpayers from waste like this.' The administration's crash-and-burn dismissal of the solar system's trailblazing robotic discoverers has triggered trepidation across NASA, whose ranks of pioneering scientists are likewise set to be culled. Within NASA, Alan Stern is a pole star of cutting-edge exploration, helping guide more than two dozen missions. After his New Horizons spacecraft rendezvoused with Pluto, the agency bestowed its highest honor on him - the NASA Distinguished Public Service Medal. 'Stern led the team that returned remarkable imagery and other data from the Pluto system last summer, generating headlines worldwide and setting a record for the farthest world ever explored,' NASA's leaders said. "New Horizons represents the best of humanity and reminds us of why we explore,' added Jim Green, NASA's director of planetary science. "The first flyby of Pluto is a remarkable achievement.' Being given the chance to lead the close encounter with Pluto, Stern said on accepting the award, 'has been the greatest honor of my lifetime.' Around the same time, NASA film-makers paid tribute to Stern, his 2000+ Pluto mission colleagues, and the target of their interplanetary expedition in the captivating documentary ' The Year of Pluto .' Stern has himself chronicled his trek across the twilight reaches of the star system in a stream of fascinating books, including Pluto and Charon: Ice Worlds on the Ragged Edge of the Solar System and Chasing New Horizons, and in a torrent of acclaimed papers . Scholar Stern predicts that if the White House's proposed death sentence for flotillas of pathfinding space missions is actually carried out, that would mark the decline and fall of NASA's planetary science breakthroughs, and the comparative rise of its competitors in the renewed space race of the 2020s. If NASA's funding and inter-planet journeys are decimated, he tells me, 'These cuts will absolutely destroy U.S. leadership in all the space sciences.' 'This is tragically misguided.' The potential death knell for an armada of space discovery missions has been reverberating not just across NASA, but also throughout the U.S. universities that help conceive or design these flights. 'Certainly termination of the New Horizons mission would be terrible,' says Kip Hodges , who as founding director of Arizona State University's School of Earth and Space Exploration helped transform the university into one of the top American space studies centers. 'This a real frontier mission at this point,' he tells me in an interview, 'delivering important new information about distant parts of our Sun's heliosphere.' Congress has the power to save NASA and its leading-edge robotic explorers across the solar system ... More (Illustration by Tobias Roetsch/Future Publishing via Getty Images) Future Publishing via Getty Images Professor Hodges , one of the top space scholars in the U.S., predicts that the Swords of Damocles now hanging above New Horizons and other new-frontier flights could still be lifted. If the White House plan to cut away at NASA and its revolutionary planetary scouting missions were enacted as is, he predicts, 'a great many folks in industry, the NASA labs, and academia will be disappointed.' Yet he adds that 'the budget for NASA evolves over several stages,' with the president's initial proposal just one of competing models—one that could be rejected as the Senate and House of Representatives look afresh at NASA's missions, goals and funding. After the twin chambers reach a consensus on reshaping NASA for the next phase of its evolution, Professor Hodges adds, 'Quite often, the appropriated budget is not the president's budget.' That means space aficionados across America who seek to overturn the president's capital sentence on NASA's boundary-breaking missions have a clear channel of recourse, Stern says. Would-be petitioners for a reprieve, he advises, 'should contact their elected representatives in Congress and tell them this is a huge mistake.'

This Poop 'Cure' May Have Unintended Long-Term Effects, Study Finds
This Poop 'Cure' May Have Unintended Long-Term Effects, Study Finds

Yahoo

time2 hours ago

  • Yahoo

This Poop 'Cure' May Have Unintended Long-Term Effects, Study Finds

Faecal microbial transplants (FMT), which involve transferring stool samples from a healthy gut to someone else's colon, have yielded some impressive medical results in the past. Researchers have seen promising signs of its ability to address irritable bowel syndrome, Crohn's disease, and even early Parkinson's (though this benefit only seemed to be short-lived) and other neurological issues. It has a 90% success rate for treating a bacterium related to diarrhoea, the BBC reported. But a new study published in the journal Cells has raised questions about the long-term safety of FMT treatments, suggesting that a bacterial 'mismatch' may cause problems with the patient's immune system and metabolism down the line. The scientists only found the link in mice and were not able to say how the changes they witnessed in the animals might manifest in people. They gave antibiotics to mice to interrupt their gut's normal microbiome, and then treated them with FMT and monitored them for one to three months. Often, the researchers discovered, the gut bacteria ended up in the wrong part of the gut – 'regional mismatches' – that seemed to disrupt the gut. After taking biopsies of the liver and gut, the scientists found that some genes, especially those related to the immune system and metabolism, had changed. Speaking to the University of Chicago, the study's lead author, researcher Orlando 'Landon' DeLeon said: 'I think it's a bit of a wake-up call to the field that maybe we shouldn't willy-nilly put large bowel microbes into different parts of the intestine that shouldn't be there. 'There are microbes along the entire intestinal tract, and we just study predominantly the last third of it (the colon),' he added. 'So how can you expect an FMT, with microbes from a third of the intestinal tract at the end of it, to fix the rest of the intestine?' No. This study was done on mice, which have different anatomies from us; even though the scientists found genetic changes in the liver and gut, they are not sure yet how those changes might affect even the mouse, never mind us. The study's researchers, however, still think it's a good idea to pursue 'omni-microbial transplants,' or OMT, writing in their paper: 'regional microbial mismatches after FMTs can lead to unintended consequences and require rethinking of microbiome-based interventions.' OMTs would include more bacteria from a greater area of the gut, theoretically increasing the likelihood that the correct ones will go to the right spot. Gut Health Discovery Could Help Future Parkinson's Diagnoses Let's Settle This – Is The Viral 'Puff Vs Pit' Armpit Health Check Actually Helpful? New Study Finds The Exact Age Bad Health Habits Catch Up To You

Can Behavioral Support Enhance CGM Use in T1D?
Can Behavioral Support Enhance CGM Use in T1D?

Medscape

time2 hours ago

  • Medscape

Can Behavioral Support Enhance CGM Use in T1D?

TOPLINE: Behavioral support for first-time users of a continuous glucose monitoring (CGM) device showed no significant difference in reduction of A1c levels compared with CGM alone in the management of type 1 diabetes (T1D). Adults in both groups reported reduced diabetes distress. METHODOLOGY: Automated insulin delivery systems are the standard of care for adults with T1D, and using them requires both an insulin pump and a CGM device. A randomized controlled trial was conducted to assess the use of CGM among 134 adults with T1D who had not previously used CGM (mean age, 35 years; 77% women; 55% not using an insulin pump) who were recruited from clinics and T1D organizations across the United States. Participants were randomly assigned to one of two groups: one received CGM alone and the other received CGM plus the ONBOARD behavioral intervention, both for 3 months. The ONBOARD intervention included four 60-minute virtual, 1:1 biweekly sessions to address barriers related to wearing the device, data management, social concerns, and trust. Changes in A1c levels and diabetes distress scores were evaluated using t-tests and linear mixed-effect models over 12 months. TAKEAWAY: At 12 months after initiating CGM, 80% of participants in the ONBOARD group and 71% in the CGM-only group reported using CGM. Both the CGM-only and ONBOARD groups showed significant reductions in A1c levels (P < .05), with no significant difference between the groups. Participants in both groups experienced significant and clinically meaningful decreases in diabetes distress (P < .001). The CGM-only group showed greater reductions in diabetes distress than the ONBOARD group at 3 months; reductions were similar between groups at 6 and 12 months. IN PRACTICE: "Findings highlight benefits of introducing CGM on diabetes management and diabetes distress for adults with T1D. Most participants were still using CGM 12 months after initiating use through the study, indicating durable uptake," the authors write. SOURCE: The study was led by Molly L. Tanenbaum, PhD, Stanford University School of Medicine, California. The poster will be presented on June 23 at the American Diabetes Association (ADA) 85th Scientific Sessions, being held June 20-23 at the McCormick Place Convention Center, Chicago, Illinois. LIMITATIONS: No study limitations were discussed in the abstract. DISCLOSURES: One author disclosed consulting roles with Sanofi and Havas Health, an advisory role with MannKind Corporation, and receiving research support from embecta. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store